New Delhi, April 16 -- A new antibiotic pill has shown promise in treating the sexually transmitted infection gonorrhoea, including forms of the infection that no longer respond to existing drugs. The results offer hope at a time when health officials warn that gonorrhoea may soon become much harder to treat.

The new drug, called gepotidacin, was tested in a major international study published in the journal The Lancet on April 14, 2025. The drug is already used to treat urinary tract infections. This is the first new gonorrhoea treatment in decades that's shown strong results.

The researchers found that the pill worked just as well as the current standard treatment, which involves two different types of antibiotics - an injection of c...